Global Biofermin Market Growth 2025-2031

December 2025 | 87 pages | ID: G80D569E0C2EN
LP Information

Abstracts

The global Biofermin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Lactase is a drying agent of live enterococcus. It decomposes sugars into lactic acid in the intestine, which increases the acidity of the intestine, inhibits the growth and reproduction of putrefactive bacteria, prevents intestinal fermentation and reduces gas production, thus promoting digestion and stopping diarrhea.

United States market for Biofermin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Biofermin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Biofermin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Biofermin players cover Guilin Pharmaceutical, Sinoway Pharmaceutical, Hebei Huanhai Pharmaceutical, Hebei Tianyuan Pharmaceutical, Shandong Baiwei Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Biofermin Industry Forecast” looks at past sales and reviews total world Biofermin sales in 2024, providing a comprehensive analysis by region and market sector of projected Biofermin sales for 2025 through 2031. With Biofermin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biofermin industry.

This Insight Report provides a comprehensive analysis of the global Biofermin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biofermin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biofermin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biofermin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biofermin.

This report presents a comprehensive overview, market shares, and growth opportunities of Biofermin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tablets
• Powdery
• Other

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Guilin Pharmaceutical
• Sinoway Pharmaceutical
• Hebei Huanhai Pharmaceutical
• Hebei Tianyuan Pharmaceutical
• Shandong Baiwei Pharmaceutical
• Huibei Widely Chemical Technology
• Okobaike Biotechnology
• Taisho

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biofermin market?

What factors are driving Biofermin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biofermin market opportunities vary by end market size?

How does Biofermin break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biofermin Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Biofermin by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Biofermin by Country/Region, 2020, 2024 & 2031
2.2 Biofermin Segment by Type
  2.2.1 Tablets
  2.2.2 Powdery
  2.2.3 Other
2.3 Biofermin Sales by Type
  2.3.1 Global Biofermin Sales Market Share by Type (2020-2025)
  2.3.2 Global Biofermin Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Biofermin Sale Price by Type (2020-2025)
2.4 Biofermin Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Biofermin Sales by Application
  2.5.1 Global Biofermin Sale Market Share by Application (2020-2025)
  2.5.2 Global Biofermin Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Biofermin Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Biofermin Breakdown Data by Company
  3.1.1 Global Biofermin Annual Sales by Company (2020-2025)
  3.1.2 Global Biofermin Sales Market Share by Company (2020-2025)
3.2 Global Biofermin Annual Revenue by Company (2020-2025)
  3.2.1 Global Biofermin Revenue by Company (2020-2025)
  3.2.2 Global Biofermin Revenue Market Share by Company (2020-2025)
3.3 Global Biofermin Sale Price by Company
3.4 Key Manufacturers Biofermin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Biofermin Product Location Distribution
  3.4.2 Players Biofermin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BIOFERMIN BY GEOGRAPHIC REGION

4.1 World Historic Biofermin Market Size by Geographic Region (2020-2025)
  4.1.1 Global Biofermin Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Biofermin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Biofermin Market Size by Country/Region (2020-2025)
  4.2.1 Global Biofermin Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Biofermin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biofermin Sales Growth
4.4 APAC Biofermin Sales Growth
4.5 Europe Biofermin Sales Growth
4.6 Middle East & Africa Biofermin Sales Growth

5 AMERICAS

5.1 Americas Biofermin Sales by Country
  5.1.1 Americas Biofermin Sales by Country (2020-2025)
  5.1.2 Americas Biofermin Revenue by Country (2020-2025)
5.2 Americas Biofermin Sales by Type (2020-2025)
5.3 Americas Biofermin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biofermin Sales by Region
  6.1.1 APAC Biofermin Sales by Region (2020-2025)
  6.1.2 APAC Biofermin Revenue by Region (2020-2025)
6.2 APAC Biofermin Sales by Type (2020-2025)
6.3 APAC Biofermin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Biofermin by Country
  7.1.1 Europe Biofermin Sales by Country (2020-2025)
  7.1.2 Europe Biofermin Revenue by Country (2020-2025)
7.2 Europe Biofermin Sales by Type (2020-2025)
7.3 Europe Biofermin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biofermin by Country
  8.1.1 Middle East & Africa Biofermin Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Biofermin Revenue by Country (2020-2025)
8.2 Middle East & Africa Biofermin Sales by Type (2020-2025)
8.3 Middle East & Africa Biofermin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biofermin
10.3 Manufacturing Process Analysis of Biofermin
10.4 Industry Chain Structure of Biofermin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Biofermin Distributors
11.3 Biofermin Customer

12 WORLD FORECAST REVIEW FOR BIOFERMIN BY GEOGRAPHIC REGION

12.1 Global Biofermin Market Size Forecast by Region
  12.1.1 Global Biofermin Forecast by Region (2026-2031)
  12.1.2 Global Biofermin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Biofermin Forecast by Type (2026-2031)
12.7 Global Biofermin Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Guilin Pharmaceutical
  13.1.1 Guilin Pharmaceutical Company Information
  13.1.2 Guilin Pharmaceutical Biofermin Product Portfolios and Specifications
  13.1.3 Guilin Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Guilin Pharmaceutical Main Business Overview
  13.1.5 Guilin Pharmaceutical Latest Developments
13.2 Sinoway Pharmaceutical
  13.2.1 Sinoway Pharmaceutical Company Information
  13.2.2 Sinoway Pharmaceutical Biofermin Product Portfolios and Specifications
  13.2.3 Sinoway Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Sinoway Pharmaceutical Main Business Overview
  13.2.5 Sinoway Pharmaceutical Latest Developments
13.3 Hebei Huanhai Pharmaceutical
  13.3.1 Hebei Huanhai Pharmaceutical Company Information
  13.3.2 Hebei Huanhai Pharmaceutical Biofermin Product Portfolios and Specifications
  13.3.3 Hebei Huanhai Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Hebei Huanhai Pharmaceutical Main Business Overview
  13.3.5 Hebei Huanhai Pharmaceutical Latest Developments
13.4 Hebei Tianyuan Pharmaceutical
  13.4.1 Hebei Tianyuan Pharmaceutical Company Information
  13.4.2 Hebei Tianyuan Pharmaceutical Biofermin Product Portfolios and Specifications
  13.4.3 Hebei Tianyuan Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Hebei Tianyuan Pharmaceutical Main Business Overview
  13.4.5 Hebei Tianyuan Pharmaceutical Latest Developments
13.5 Shandong Baiwei Pharmaceutical
  13.5.1 Shandong Baiwei Pharmaceutical Company Information
  13.5.2 Shandong Baiwei Pharmaceutical Biofermin Product Portfolios and Specifications
  13.5.3 Shandong Baiwei Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Shandong Baiwei Pharmaceutical Main Business Overview
  13.5.5 Shandong Baiwei Pharmaceutical Latest Developments
13.6 Huibei Widely Chemical Technology
  13.6.1 Huibei Widely Chemical Technology Company Information
  13.6.2 Huibei Widely Chemical Technology Biofermin Product Portfolios and Specifications
  13.6.3 Huibei Widely Chemical Technology Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Huibei Widely Chemical Technology Main Business Overview
  13.6.5 Huibei Widely Chemical Technology Latest Developments
13.7 Okobaike Biotechnology
  13.7.1 Okobaike Biotechnology Company Information
  13.7.2 Okobaike Biotechnology Biofermin Product Portfolios and Specifications
  13.7.3 Okobaike Biotechnology Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Okobaike Biotechnology Main Business Overview
  13.7.5 Okobaike Biotechnology Latest Developments
13.8 Taisho
  13.8.1 Taisho Company Information
  13.8.2 Taisho Biofermin Product Portfolios and Specifications
  13.8.3 Taisho Biofermin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Taisho Main Business Overview
  13.8.5 Taisho Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biofermin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biofermin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Powdery
Table 5. Major Players of Other
Table 6. Global Biofermin Sales by Type (2020-2025) & (MT)
Table 7. Global Biofermin Sales Market Share by Type (2020-2025)
Table 8. Global Biofermin Revenue by Type (2020-2025) & ($ million)
Table 9. Global Biofermin Revenue Market Share by Type (2020-2025)
Table 10. Global Biofermin Sale Price by Type (2020-2025) & (USD/Kg)
Table 11. Global Biofermin Sale by Application (2020-2025) & (MT)
Table 12. Global Biofermin Sale Market Share by Application (2020-2025)
Table 13. Global Biofermin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Biofermin Revenue Market Share by Application (2020-2025)
Table 15. Global Biofermin Sale Price by Application (2020-2025) & (USD/Kg)
Table 16. Global Biofermin Sales by Company (2020-2025) & (MT)
Table 17. Global Biofermin Sales Market Share by Company (2020-2025)
Table 18. Global Biofermin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Biofermin Revenue Market Share by Company (2020-2025)
Table 20. Global Biofermin Sale Price by Company (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Biofermin Producing Area Distribution and Sales Area
Table 22. Players Biofermin Products Offered
Table 23. Biofermin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Biofermin Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Biofermin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Biofermin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Biofermin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Biofermin Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Biofermin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Biofermin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Biofermin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Biofermin Sales by Country (2020-2025) & (MT)
Table 35. Americas Biofermin Sales Market Share by Country (2020-2025)
Table 36. Americas Biofermin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Biofermin Sales by Type (2020-2025) & (MT)
Table 38. Americas Biofermin Sales by Application (2020-2025) & (MT)
Table 39. APAC Biofermin Sales by Region (2020-2025) & (MT)
Table 40. APAC Biofermin Sales Market Share by Region (2020-2025)
Table 41. APAC Biofermin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Biofermin Sales by Type (2020-2025) & (MT)
Table 43. APAC Biofermin Sales by Application (2020-2025) & (MT)
Table 44. Europe Biofermin Sales by Country (2020-2025) & (MT)
Table 45. Europe Biofermin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Biofermin Sales by Type (2020-2025) & (MT)
Table 47. Europe Biofermin Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Biofermin Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Biofermin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Biofermin Sales by Type (2020-2025) & (MT)
Table 51. Middle East & Africa Biofermin Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Biofermin
Table 53. Key Market Challenges & Risks of Biofermin
Table 54. Key Industry Trends of Biofermin
Table 55. Biofermin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Biofermin Distributors List
Table 58. Biofermin Customer List
Table 59. Global Biofermin Sales Forecast by Region (2026-2031) & (MT)
Table 60. Global Biofermin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Biofermin Sales Forecast by Country (2026-2031) & (MT)
Table 62. Americas Biofermin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Biofermin Sales Forecast by Region (2026-2031) & (MT)
Table 64. APAC Biofermin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Biofermin Sales Forecast by Country (2026-2031) & (MT)
Table 66. Europe Biofermin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Biofermin Sales Forecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Biofermin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Biofermin Sales Forecast by Type (2026-2031) & (MT)
Table 70. Global Biofermin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Biofermin Sales Forecast by Application (2026-2031) & (MT)
Table 72. Global Biofermin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Guilin Pharmaceutical Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 74. Guilin Pharmaceutical Biofermin Product Portfolios and Specifications
Table 75. Guilin Pharmaceutical Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 76. Guilin Pharmaceutical Main Business
Table 77. Guilin Pharmaceutical Latest Developments
Table 78. Sinoway Pharmaceutical Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sinoway Pharmaceutical Biofermin Product Portfolios and Specifications
Table 80. Sinoway Pharmaceutical Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. Sinoway Pharmaceutical Main Business
Table 82. Sinoway Pharmaceutical Latest Developments
Table 83. Hebei Huanhai Pharmaceutical Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 84. Hebei Huanhai Pharmaceutical Biofermin Product Portfolios and Specifications
Table 85. Hebei Huanhai Pharmaceutical Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 86. Hebei Huanhai Pharmaceutical Main Business
Table 87. Hebei Huanhai Pharmaceutical Latest Developments
Table 88. Hebei Tianyuan Pharmaceutical Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 89. Hebei Tianyuan Pharmaceutical Biofermin Product Portfolios and Specifications
Table 90. Hebei Tianyuan Pharmaceutical Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 91. Hebei Tianyuan Pharmaceutical Main Business
Table 92. Hebei Tianyuan Pharmaceutical Latest Developments
Table 93. Shandong Baiwei Pharmaceutical Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 94. Shandong Baiwei Pharmaceutical Biofermin Product Portfolios and Specifications
Table 95. Shandong Baiwei Pharmaceutical Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. Shandong Baiwei Pharmaceutical Main Business
Table 97. Shandong Baiwei Pharmaceutical Latest Developments
Table 98. Huibei Widely Chemical Technology Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 99. Huibei Widely Chemical Technology Biofermin Product Portfolios and Specifications
Table 100. Huibei Widely Chemical Technology Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 101. Huibei Widely Chemical Technology Main Business
Table 102. Huibei Widely Chemical Technology Latest Developments
Table 103. Okobaike Biotechnology Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 104. Okobaike Biotechnology Biofermin Product Portfolios and Specifications
Table 105. Okobaike Biotechnology Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 106. Okobaike Biotechnology Main Business
Table 107. Okobaike Biotechnology Latest Developments
Table 108. Taisho Basic Information, Biofermin Manufacturing Base, Sales Area and Its Competitors
Table 109. Taisho Biofermin Product Portfolios and Specifications
Table 110. Taisho Biofermin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 111. Taisho Main Business
Table 112. Taisho Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Biofermin
Figure 2. Biofermin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biofermin Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Biofermin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biofermin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biofermin Sales Market Share by Country/Region (2024)
Figure 10. Biofermin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Powdery
Figure 13. Product Picture of Other
Figure 14. Global Biofermin Sales Market Share by Type in 2025
Figure 15. Global Biofermin Revenue Market Share by Type (2020-2025)
Figure 16. Biofermin Consumed in Hospital Pharmacies
Figure 17. Global Biofermin Market: Hospital Pharmacies (2020-2025) & (MT)
Figure 18. Biofermin Consumed in Retail Pharmacies
Figure 19. Global Biofermin Market: Retail Pharmacies (2020-2025) & (MT)
Figure 20. Biofermin Consumed in Online Pharmacies
Figure 21. Global Biofermin Market: Online Pharmacies (2020-2025) & (MT)
Figure 22. Global Biofermin Sale Market Share by Application (2024)
Figure 23. Global Biofermin Revenue Market Share by Application in 2025
Figure 24. Biofermin Sales by Company in 2025 (MT)
Figure 25. Global Biofermin Sales Market Share by Company in 2025
Figure 26. Biofermin Revenue by Company in 2025 ($ millions)
Figure 27. Global Biofermin Revenue Market Share by Company in 2025
Figure 28. Global Biofermin Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Biofermin Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Biofermin Sales 2020-2025 (MT)
Figure 31. Americas Biofermin Revenue 2020-2025 ($ millions)
Figure 32. APAC Biofermin Sales 2020-2025 (MT)
Figure 33. APAC Biofermin Revenue 2020-2025 ($ millions)
Figure 34. Europe Biofermin Sales 2020-2025 (MT)
Figure 35. Europe Biofermin Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Biofermin Sales 2020-2025 (MT)
Figure 37. Middle East & Africa Biofermin Revenue 2020-2025 ($ millions)
Figure 38. Americas Biofermin Sales Market Share by Country in 2025
Figure 39. Americas Biofermin Revenue Market Share by Country (2020-2025)
Figure 40. Americas Biofermin Sales Market Share by Type (2020-2025)
Figure 41. Americas Biofermin Sales Market Share by Application (2020-2025)
Figure 42. United States Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Biofermin Sales Market Share by Region in 2025
Figure 47. APAC Biofermin Revenue Market Share by Region (2020-2025)
Figure 48. APAC Biofermin Sales Market Share by Type (2020-2025)
Figure 49. APAC Biofermin Sales Market Share by Application (2020-2025)
Figure 50. China Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 54. India Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Biofermin Sales Market Share by Country in 2025
Figure 58. Europe Biofermin Revenue Market Share by Country (2020-2025)
Figure 59. Europe Biofermin Sales Market Share by Type (2020-2025)
Figure 60. Europe Biofermin Sales Market Share by Application (2020-2025)
Figure 61. Germany Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 62. France Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Biofermin Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Biofermin Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Biofermin Sales Market Share by Application (2020-2025)
Figure 69. Egypt Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Biofermin Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Biofermin in 2025
Figure 75. Manufacturing Process Analysis of Biofermin
Figure 76. Industry Chain Structure of Biofermin
Figure 77. Channels of Distribution
Figure 78. Global Biofermin Sales Market Forecast by Region (2026-2031)
Figure 79. Global Biofermin Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Biofermin Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Biofermin Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Biofermin Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Biofermin Revenue Market Share Forecast by Application (2026-2031)